Ascend Wellness Holdings, Inc. (OTC:AAWH - Free Report) - Equities researchers at Atb Cap Markets issued their Q1 2025 earnings per share estimates for shares of Ascend Wellness in a research note issued to investors on Thursday, March 13th. Atb Cap Markets analyst F. Gomes anticipates that the company will post earnings per share of ($0.07) for the quarter. The consensus estimate for Ascend Wellness' current full-year earnings is ($0.40) per share. Atb Cap Markets also issued estimates for Ascend Wellness' Q2 2025 earnings at ($0.07) EPS, Q3 2025 earnings at ($0.06) EPS, Q4 2025 earnings at ($0.05) EPS, FY2025 earnings at ($0.25) EPS, FY2026 earnings at ($0.14) EPS, FY2027 earnings at ($0.12) EPS and FY2028 earnings at ($0.11) EPS.
Ascend Wellness Stock Up 2.9 %
Shares of Ascend Wellness stock traded up $0.01 during trading hours on Monday, hitting $0.36. 112,425 shares of the company's stock traded hands, compared to its average volume of 125,264. The stock has a 50 day simple moving average of $0.37 and a 200-day simple moving average of $0.56. The company has a quick ratio of 0.80, a current ratio of 1.47 and a debt-to-equity ratio of 2.61. The company has a market cap of $77.19 million, a PE ratio of -0.88 and a beta of 1.27. Ascend Wellness has a twelve month low of $0.27 and a twelve month high of $1.55.
Ascend Wellness Company Profile
(
Get Free Report)
Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands.
Featured Articles

Before you consider Ascend Wellness, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ascend Wellness wasn't on the list.
While Ascend Wellness currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.